These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 17905466

  • 1. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
    Skov BG, Fischer BM, Pappot H.
    Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B, Pappot H, Holmstav J, Skov BG.
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [Abstract] [Full Text] [Related]

  • 3. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 4. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
    Nose N, Sugio K, Oyama T, Nozoe T, Uramoto H, Iwata T, Onitsuka T, Yasumoto K.
    J Clin Oncol; 2009 Jan 20; 27(3):411-7. PubMed ID: 19064969
    [Abstract] [Full Text] [Related]

  • 5. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Middleton LP, Perkins GH, Tucker SL, Sahin AA, Singletary SE.
    Histopathology; 2007 Jun 20; 50(7):875-80. PubMed ID: 17543077
    [Abstract] [Full Text] [Related]

  • 6. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S, Unsal E, Demirag F, Köksal D, Yilmaz A.
    Respir Med; 2006 Dec 20; 100(12):2220-6. PubMed ID: 16650973
    [Abstract] [Full Text] [Related]

  • 7. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers.
    Wu CT, Chang YL, Shih JY, Lee YC.
    J Thorac Cardiovasc Surg; 2005 Oct 20; 130(4):979-86. PubMed ID: 16214508
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
    Hsu LH, Chu NM, Liu CC, Tsai SY, You DL, Ko JS, Lu MC, Feng AC.
    Lung Cancer; 2009 Nov 20; 66(2):262-7. PubMed ID: 19299032
    [Abstract] [Full Text] [Related]

  • 11. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S, Holm C, Stendahl M, Anagnostaki L, Landberg G, Jirström K.
    J Clin Pathol; 2008 Feb 20; 61(2):197-203. PubMed ID: 18223096
    [Abstract] [Full Text] [Related]

  • 12. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
    Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y, Ogawa J.
    Clin Cancer Res; 2005 Jul 15; 11(14):5084-9. PubMed ID: 16033821
    [Abstract] [Full Text] [Related]

  • 13. Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: pathologic and prognostic correlations.
    Vargas SO, Leslie KO, Vacek PM, Socinski MA, Weaver DL.
    Cancer; 1998 Apr 15; 82(8):1495-500. PubMed ID: 9554526
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Edén P, Peterson C, Malmström P, Isola J, Borg A, Fernö M.
    Clin Cancer Res; 2007 Apr 01; 13(7):1987-94. PubMed ID: 17404078
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 01; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 17. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
    Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, Finkelstein S, Siegfried JM.
    Cancer Res; 2002 Apr 01; 62(7):2141-50. PubMed ID: 11929836
    [Abstract] [Full Text] [Related]

  • 18. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer.
    Sienel W, Dango S, Woelfle U, Morresi-Hauf A, Wagener C, Brümmer J, Mutschler W, Passlick B, Pantel K.
    Clin Cancer Res; 2003 Jun 01; 9(6):2260-6. PubMed ID: 12796394
    [Abstract] [Full Text] [Related]

  • 19. Oestrogen receptor β in NSCLC - prevalence, proliferative influence, prognostic impact and smoking.
    Karlsson C, Helenius G, Fernandes O, Karlsson MG.
    APMIS; 2012 Jun 01; 120(6):451-8. PubMed ID: 22583357
    [Abstract] [Full Text] [Related]

  • 20. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
    Niikawa H, Suzuki T, Miki Y, Suzuki S, Nagasaki S, Akahira J, Honma S, Evans DB, Hayashi S, Kondo T, Sasano H.
    Clin Cancer Res; 2008 Jul 15; 14(14):4417-26. PubMed ID: 18579664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.